Matinas BioPharma Holdings, Inc. MTNB 深 沪
等待开盘 06-05 09:30:00 美东时间
0.7842
+0.006
+0.80%
华盛通- 最 高0.795
- 今 开0.795
- 成交量 6989股
- 最 低 0.7842
- 昨 收 0.778
- 总市值 502.37万
- 52周最高 3.09
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 0.48
- 委 比 -90.48%
- 总股本 640.62万
- 历史最高 197.50
- 量 比 0.08
- 振 幅 1.39%
- 历史最低 0.4748
- 每 手 1
- 风险率 0.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Matinas BioPharma Hldgs Q1 EPS $(0.30) Up From $(0.33) YoY
Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.30) per share. This is a 9.09 percent increase over losses of $(0.33) per share from the same period last year.
05-09 06:07
Matinas BioPharma receives notice from NYSE
Matinas BioPharma (NYSE: MTNB) said on Friday it received a notice from NYSE American on April 2, 2026, for non-compliance with Section 1003(a)(i) listing standard. NYSE American said the company fail...
04-04 05:20
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Matinas BioPharma Holdings, Inc. received a notice from NYSE American indicating non-compliance with continued listing standards due to insufficient stockholders' equity and losses over recent fiscal years. The company has until May 2, 2026, to submit a compliance plan and up to 18 months to regain compliance. The notice does not affect the company's stock listing or operations. Matinas BioPharma focuses on developing therapies using lipid nanocr...
04-03 21:00
Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY
Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.26) per share. This is a 84.52 percent increase over losses of $(1.68) per share from the same period last year.
04-01 06:50
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Shares of Marriott Vacations Worldwide Corp (NYSE:VAC) rose sharply in pre-mark...
02-26 17:38
Matinas BioPharma CFO Keith Kucinski Resigns; CEO Jerome Jabbour Appointed Interim CFO
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported, on November 18, 2025, Keith Kucinski, Chief
01-24 06:08
Matinas BioPharma CFO Resignation Announced
Matinas BioPharma ( ($MTNB) ) just unveiled an update. On November 18, 2025, Ma...
2025-11-22 06:51
Matinas BioPharma Hldgs Q3 EPS $(0.40) Up From $(0.85) YoY
Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.40) per share. This is a 52.94 percent increase over losses of $(0.85) per share from the same period last year.
2025-11-11 06:49
Matinas BioPharma Cancels Warrants in Stock Exchange
Matinas BioPharma ( ($MTNB) ) just unveiled an update. On August 15, 2025, Mati...
2025-08-18 18:57
Matinas BioPharma Doubles Authorized Common Shares To 500M Following Shareholder Approval
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year. On August 6, 2025, Matinas BioPharma Holdings, Inc. (the "Company") filed a Certificate of Amendment (the "Certificate of
2025-08-07 06:19
